Korea United Pharm KRX:033270KOSPI
유나이티드 · Korean news coverage and regulatory filings, organized.
Articles, 24h2
Articles, 7 days4
DART filings, 7 days0
Articles tracked4since Sep 11
In Q2 2026, Korea United Pharm reported revenue of ₩77.2bn, up 9.7% year on year, and operating profit of ₩13.3bn. Korea United Pharm (유나이티드) appeared in 4 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Sep 14 with 3 articles.
Korea United Pharm quarterly results separate, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩77.2bn | +9.7% | ₩13.3bn | ₩37.7bn |
| Q1 2026 | ₩73.8bn | +3.5% | ₩11.3bn | ₩14.0bn |
| Q4 2025 derived | ₩72.6bn | -0.7% | ₩12.5bn | ₩10.9bn |
| Q3 2025 | ₩74.4bn | +4.3% | ₩12.5bn | ₩13.5bn |
| Q2 2025 | ₩70.4bn | -0.9% | ₩10.8bn | ₩1.2bn |
| Q1 2025 | ₩71.3bn | -2.5% | ₩13.8bn | ₩12.7bn |
| Q4 2024 derived | ₩73.2bn | +3.1% | ₩11.8bn | ₩14.4bn |
| Q3 2024 | ₩71.4bn | +1.1% | ₩15.1bn | ₩5.3bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.
Korea United Pharm top stories 2 weeks, by number of outlets
- 1
- 2
- 3
- 4
